Decision taken after Moderna submitted all documents to fulfil UAE regulations
Dubai: The Ministry of Health and Prevention (MoHAP) on Sunday announced the approval of the emergency registration of Moderna’s COVID-19 vaccine.
The decision was made following the completion of clinical trials and a strict assessment conducted to approve the local emergency use of the vaccine, as well as the approval of the US Food and Drug Administration (FDA).
The move clearly reflects the UAE’s strategy that puts the health and safety of people at the forefront of its priorities and the tireless efforts being made to counter the pandemic.
Attracting and providing effective and efficient vaccines is part of the UAE’s commitment to promoting the effective response to the pandemic, said Dr. Mohamed Salim Al-Olama, Undersecretary of the Ministry of Health and Prevention, emphasising that such step is a crucial stage to enhance the prevention and accelerate the pace of approaching the recovery phase and community immunisation.
A review of studies on vaccine safety was made based on the FDA approval, said Al Amiri, pointing out that the clinical trials have shown that the vaccine is safe and effective, and is triggering an immune response, in addition to producing COVID-19 antibodies.
“We welcome the opportunity to work alongside Magenta for the distribution of our vaccine in the UAE,” said Corinne Le Goff, Chief Commercial Officer of Moderna. “Together with our partners, we hope to advance our goal to expand access to our vaccine globally, and support governments, as with the UAE, in protecting their citizens, residents, and visitors against the pandemic.”
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox